lobbying_activities: 3139809

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3139809	fa6e1726-e379-42b5-9e12-ae5be95bfb65	Q1	ARTHRITIS FOUNDATION	4356	ARTHRITIS FOUNDATION	2024	first_quarter	MMM	out-of-pocket costs, drug prices, utilization management, prior authorization, step therapy, clinical trial diversity, COVID-19 therapeutics, pharmacist scope of practice, telehealth extensions , association health plans, self-insurance protections, short-term limited duration insurance plans -HR 830/S 1357,HELP Copays Act -HR 2630/ S. 652, Safe Step Act -S 1339, Pharmacy Benefit Manager Reform Act -HR 1770, the Equitable Community Access to Pharmacist Services Act -HR 824, the Telehealth Benefit Expansion for Workers Act -Accelerating Kid's Access to Care Act	Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE		75000	0	0	2024-04-04T13:15:03-04:00